Abstract: A monitoring device includes: an instruction unit configured to instruct a vehicle to acquire appearance data of a monitoring object designated by a user; a detection unit configured to receive the appearance data from the vehicle and to detect whether a state of the monitoring object has changed based on the appearance data; and a monitoring result notifying unit configured to notify the user of a monitoring result of the monitoring object when the detection unit detects that the state of the monitoring object has changed.

Abstract: The present invention provides a photosensitive composition which can suppress the generation of a development residue on the surface of an electrode and the corrosion of the electrode to form a black pixel division layer, and also can suppress the generation of off-pixel in an organic EL display device comprising the pixel division layer. Disclosed is a photosensitive composition comprising (a) a pigment, (b) a resin having two or more tertiary amino groups in the molecule, and (c) a photosensitive agent, wherein the component (b) contains a resin having a structure represented by the general formula (1).

Abstract: A treatment support device includes an irradiation unit configured to emit treatment light to a medical agent, a fluorescence intensity acquisition unit configured to acquire fluorescence intensity of fluorescence emitted by the fluorescent material of the medical agent excited by the treatment light, and a treatment light imaging unit configured to capture a treatment light image based on the treatment light. The treatment support device is configured such that a first region of interest is capable of being set based on a position of the treatment light in the treatment light image captured by the treatment light imaging unit, the first region of interest being a region for selectively acquiring a temporal change in the fluorescence intensity acquired by the fluorescence intensity acquisition unit.

Abstract: The present invention provides a negative-type photosensitive resin composition capable of obtaining a cured film suppressing generation of development residues caused by a pigment and having high sensitivity and excellent heat resistance and light blocking capability. A negative-type photosensitive resin composition contains an alkali-soluble resin (A), a radical-polymerizable compound (B), a photopolymerization initiator (C1), and a pigment (D1).

Abstract: This treatment support system (100) is provided with an irradiation unit (10) for irradiating a medical agent (102) administered to a subject of a cancer subject (101) with therapeutic light in treatment for killing a cancer cell by irradiating the medical agent with the therapeutic light, a light detection unit (30) for detecting fluorescence excited by the therapeutic light, a control unit (51), and a display unit (60). The control unit (51) includes a signal acquisition unit (51a) for acquiring a fluorescence signal, an analysis processing unit (51c) for generating the analysis image (203) that displays a treatment progress distribution for each region of the treatment site based on a change along time series of the fluorescence signal, and an image output unit (51d) for outputting the analysis image (203).

Abstract: A photodynamic therapy treatment support device is provided with a light source and a distribution information output unit. The light source irradiates a photosensitive substance administered to a body of a subject with light of a specific wavelength bandwidth having energy capable of generating fluorescence from the photosensitive substance without advancing necroses of tumor cells. The distribution information output unit outputs information on a distribution state of the fluorescence generated from the photosensitive substance, based on the fluorescence generated from the photosensitive substance.

Abstract: The present invention provides a photosensitive composition which can suppress the generation of a development residue on the surface of an electrode and the corrosion of the electrode to form a black pixel division layer, and also can suppress the generation of off-pixel in an organic EL display device comprising the pixel division layer. Disclosed is a photosensitive composition comprising (a) a pigment, (b) a resin having two or more tertiary amino groups in the molecule, and (c) a photosensitive agent, wherein the component (b) contains a resin having a structure represented by the general formula (1).

Abstract: An organic EL display device including a substrate, and a planarization layer, a first electrode, a pixel division layer, a light emitting pixel and a second electrode formed on the substrate, wherein the planarization layer and/or the pixel division layer contain(s) zirconium nitride particles, and a crystallite size of the zirconium nitride particles determined from a half width of a peak derived from a (111) plane in an X-ray diffraction spectrum using a CuK? ray as an X-ray source is 5 nm or more 20 nm or less. Provided are an organic EL display device with excellent visibility and fewer display defects, and a cured film which is excellent in storage stability of a photosensitive resin composition capable of being applied on an insulating layer of the organic EL display device, and which has high sensitivity and high visible light-shielding property and is also free from residue in the opening.

Abstract: The imaging apparatus includes: a first light source; a second light source; a reference scale disposed in close proximity to a subject; a first imaging unit for capturing a visible image; a second imaging unit for capturing a fluorescence image; an image display unit for displaying a visible image and a fluorescence image; an operation unit which is a user interface for inputting a desired measurement line on the fluorescence image; and a distance calculation unit for calculating a length of the measurement line based on a length of the reference scale, and the image display unit displays a length of the measurement line calculated by the distance calculation unit.

Abstract: A printer is provided with a first nozzle surface including a first nozzle row, a second nozzle surface including a second nozzle row positioned with respect to the first nozzle row in a main scanning direction, a receiver having a width smaller than an interval between the first nozzle row and the second nozzle row, and a driver. A processor of the printer causes the driver to perform a discharge driving to discharge ink from at least one of nozzles of one of the first nozzle row or the second nozzle row, and causes the driver to perform a non-discharge driving to not discharge ink from at least one of nozzles of the other of the first nozzle row or the second nozzle row, in a state of one of the first nozzle row or the second nozzle row being caused to face the receiver in a discharge direction.

Abstract: A treatment support apparatus (100) includes an excitation light source (21) configured to irradiate a fluorescent substance (301) of a drug (300) administered into a cancer patient's (200) body with excitation light in a specific waveband having energy that excites the fluorescent substance (301) but does not kill a cancer cell (301) before or after treatment to kill the cancer cell (201) based on irradiating the drug (300) containing the fluorescent substance (301) with light in a specific waveband, a fluorescence detector (26) configured to detect fluorescence emitted by the fluorescent substance (301) of the drug (300) due to excitation by the excitation light, and an image generator (16) configured to generate a fluorescence distribution image (41), which is an image showing a distribution state of the fluorescence emitted by the fluorescent substance (301), based on the fluorescence from the fluorescent substance (301) detected by the fluorescence detector (26).

Abstract: The control unit includes, as a mechanical configuration, an image processing unit and a recording control unit. The image processing unit includes a combining unit that combines the fluorescence image acquired by the illuminating/photographing unit and the visible light image, a condition designation unit that designates an analysis condition and the like of an image analysis by an analyzing unit to be described later, and an analyzing unit that performs an analysis under the analysis condition designated by the condition designation unit. The storage unit includes an image storage unit including a reproduction moving image storage unit that stores a combined moving image obtained by combining the fluorescence image and the visible light image by the combining unit in the image processing unit as an irreversibly-compressed moving image file and an analysis moving image storage unit that stores a fluorescence moving image and a visible light moving image.

Abstract: This treatment support system is provided with a treatment support device including an image processing unit and a display device for displaying a display image. The image processing unit is configured to output the display image reconstructed by changing one color component corresponding to the treatment laser light in the visible light image to another color component other than the one color component to the display device when treatment of the treatment target site is being performed by the treatment laser light.

Abstract: An organic EL display device having excellent light-emitting reliability while it has pixel division layer (8) and/or planarization layer (4) having excellent optical properties is provided.

Abstract: Provided is a method and pharmaceutical agent which make it possible to efficiently implement PIT, and a method characterized by a step of administering a pharmaceutical agent, in which a substance that binds to tumor blood vessel specific marker molecules present in new blood vessels has been conjugated with at least a labeling substance, to an object associated with a disease or pathology, and changing a physical property of the labeling substance after the administration step.

Abstract: An imaging apparatus that is easily moved between locations protects an imaging element in motion and provides a first arm member and a proximate movable second arm member. A lighting-imaging element is movably positionable proximate an arm mechanism and also proximate a rear-side location of a wheeled platform relative to a traveling direction thereby preventing damage. The first and second arm are relatively surrounded with a sub-arm and lighting-imaging element, thereby preventing further unintended movement. Accordingly, an elongating (separation) of the first and second arm members are prevented.

Abstract: A treatment support device is provided with an irradiation unit, a fluorescence detection unit, and a change acquisition unit for acquiring a change degree of a fluorescence signal detected within a first time range within a treatment time. The treatment support device is provided with: a determination unit for determining whether or not the progress of the treatment is in a steady state based on the fact that the change degree of the fluorescence signal within the first time range falls within a predetermined range of the change degree; and an operation control unit for performing predetermined operation control when the progress of the treatment is determined to be in the steady state by the determination unit.

Abstract: This brain function measurement device (100) includes a brain blood flow information acquisition unit (1) that acquires brain blood flow information (d1) of a subject (P), a brain function information acquisition unit (30) that acquires brain function correlation information (d3) indicating a relative change in a correlation between respective portions of the brain acquired on the basis of the brain blood flow information measured in a plurality of portions of a brain before and after a task is presented, and a brain function image generation unit (7) that generates a first brain function image (20) in which a relative position of each measurement position (23) for the brain blood flow information and the measurement position at which the correlation acquired on the basis of the brain function correlation information has changed are visually recognizable.

Abstract: A brain function measurement device (100) includes a brain blood flow information acquirer (1) configured to acquire brain blood flow information (d1) of a subject (P), a rest information acquirer (2) configured to acquire rest information (d5) to determine whether or not the subject is at rest, and a controller (3) configured to acquire, as resting measurement data (d2), the brain blood flow information with the rest information satisfying a predetermined condition based on the rest information acquired by the rest information acquirer.

Abstract: A treatment support system is provided with an irradiation unit for irradiating a medical agent containing a fluorescent material with treatment light, a light detection unit for detecting, out of the treatment light and fluorescence, at least the fluorescence, a storage uni, and a control unit. The control unit performs control of at least a start of storing the fluorescence signal by the storage unit based on that the fluorescence signal detected by the light detection unit has changed beyond at least a predetermined degree of change; or that the light detection unit has detected the signal of the treatment light.